Literature DB >> 16688830

Accuracy of combined PET/CT in image-guided interventions of liver lesions: an ex-vivo study.

Patrick Veit1, Christiane Kuehle, Thomas Beyer, Hilmar Kuehl, Andreas Bockisch, Gerald Antoch.   

Abstract

AIM: Positioning of interventional devices in liver lesions is a challenging task if only CT is available. We investigated the potential benefit of combined PET/CT images for localization of interventional devices in interventional liver studies.
METHODS: Thirty lesions each of hyperdense, isodense and hypodense attenuation compared to normal liver parenchyma were injected into 15 ex-vivo pig livers. All lesions were composed of the same amounts of gelatine containing 0.5 MBq of (18)F-FDG. Following lesion insertion, an interventional needle was placed in each lesion under CT-guidance solely. After that, a PET/CT study was performed. The localization of the needle within the lesion was assessed for CT alone and PET/CT and the root mean square (RMS) was calculated. Results were compared with macroscopic measurements after lesion dissection serving as the standard of reference.
RESULTS: In hypo- and isodense lesions PET/CT proved more accurate in defining the position of the interventional device when compared with CT alone. The mean RMS for CT and PET/CT differed significantly in isodense and hypodense lesions. No significant difference was found for hyperdense lesions.
CONCLUSION: Combined FDG-PET/CT imaging provides more accurate information than CT alone concerning the needle position in FDG-PET positive liver lesions. Therefore combined PET/CT might be potentially beneficial not only for localization of an interventional device, but may also be beneficial for guidance in interventional liver procedures.

Entities:  

Mesh:

Year:  2006        PMID: 16688830      PMCID: PMC4088075          DOI: 10.3748/wjg.v12.i15.2388

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

Review 1.  Image-guided radiofrequency tumor ablation: challenges and opportunities--part I.

Authors:  S Nahum Goldberg; D E Dupuy
Journal:  J Vasc Interv Radiol       Date:  2001-09       Impact factor: 3.464

Review 2.  Image-guided radiofrequency tumor ablation: challenges and opportunities--part II.

Authors:  D E Dupuy; S N Goldberg
Journal:  J Vasc Interv Radiol       Date:  2001-10       Impact factor: 3.464

3.  Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year.

Authors:  T de Baere; D Elias; C Dromain; M G Din; V Kuoch; M Ducreux; V Boige; N Lassau; V Marteau; P Lasser; A Roche
Journal:  AJR Am J Roentgenol       Date:  2000-12       Impact factor: 3.959

4.  US-guided percutaneous biopsy of small (< or = 1-cm) hepatic lesions.

Authors:  S C Yu; C T Liew; W Y Lau; T W Leung; C Metreweli
Journal:  Radiology       Date:  2001-01       Impact factor: 11.105

5.  Diagnostic yield of MR-guided liver biopsies compared with CT- and US-guided liver biopsies.

Authors:  A J Schmidt; S T Kee; D Y Sze; B L Daniel; M K Razavi; C P Semba; M D Dake
Journal:  J Vasc Interv Radiol       Date:  1999 Nov-Dec       Impact factor: 3.464

Review 6.  Comparison of fine needle aspiration cytology and needle core biopsy in the diagnosis of radiologically detected abdominal lesions.

Authors:  C J R Stewart; J Coldewey; I S Stewart
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

7.  Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer.

Authors:  S Rossi; M Di Stasi; E Buscarini; P Quaretti; F Garbagnati; L Squassante; C T Paties; D E Silverman; L Buscarini
Journal:  AJR Am J Roentgenol       Date:  1996-09       Impact factor: 3.959

8.  Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications.

Authors:  T F Wood; D M Rose; M Chung; D P Allegra; L J Foshag; A J Bilchik
Journal:  Ann Surg Oncol       Date:  2000-09       Impact factor: 5.344

9.  A combined PET/CT scanner for clinical oncology.

Authors:  T Beyer; D W Townsend; T Brun; P E Kinahan; M Charron; R Roddy; J Jerin; J Young; L Byars; R Nutt
Journal:  J Nucl Med       Date:  2000-08       Impact factor: 10.057

10.  Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up.

Authors:  Clarisse Dromain; Thierry de Baere; Dominique Elias; Viseth Kuoch; Michel Ducreux; Valerie Boige; Peter Petrow; Alain Roche; Robert Sigal
Journal:  Radiology       Date:  2002-04       Impact factor: 11.105

View more
  4 in total

1.  Incorporation of preprocedural PET into CT-guided radiofrequency ablation of hepatic metastases: a nonrigid image registration validation study.

Authors:  Peng Lei; Omkar Dandekar; David Widlus; Raj Shekhar
Journal:  J Digit Imaging       Date:  2009-05-27       Impact factor: 4.056

2.  The current role of PET-CT in the characterization of hepatobiliary malignancies.

Authors:  Ginseppe Garcea; Seok Ling Ong; Guy J Maddern
Journal:  HPB (Oxford)       Date:  2009-02       Impact factor: 3.647

3.  PET-CT-guided interventions in the management of FDG-positive lesions in patients suffering from solid malignancies: initial experiences.

Authors:  Bernd Klaeser; Michel D Mueller; Ralph A Schmid; Carlos Guevara; Thomas Krause; Jakub Wiskirchen
Journal:  Eur Radiol       Date:  2009-02-24       Impact factor: 5.315

4.  The impact of coaxial core biopsy guided by FDG PET/CT in oncological patients.

Authors:  Juliano Julio Cerci; Carlos Cunha Pereira Neto; Cassiano Krauzer; Danielle Giacometti Sakamoto; João Vicente Vitola
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-26       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.